We are pleased to announce that Dr. Pete Yeh’s research on liver cancer treatment has been selected as one of the two best clinical poster presentations at this year’s Particle Therapy Co-Operative Group North America (PTCOG-NA) meeting in New York.
Dr. Yeh’s research, ‘Local recurrence in hepatocellular carcinoma: Role of tumor location and motion management with proton beam therapy,’ explores key factors that could enhance the precision and effectiveness of proton therapy for liver cancer patients.
Being chosen for this honor from among numerous submissions across North America is a testament to Dr. Yeh’s dedication to advancing cancer treatment through thoughtful, patient-focused research. He’ll be presenting his findings at PTCOG-NA in New York, November 14-16, 2024.
Please join us in congratulating Dr. Yeh on this well-deserved recognition. Way to go, Dr. Yeh!
